The Effects of Troglitazone on Human Health
June 12, 2002
photo-3Brent A. Neuschwander-Tetri, M.D. has been with Saint Louis University Health Sciences Center since 1991. As a faculty member, his specialty is liver disease, with a special interest in non-alcoholic steatohepatitis (NASH). Dr. Neuschwander-Tetri is a well published author, and has consulted on legal cases involving potential troglitazone (Rezulin) toxicity in diabetic patients. He spoke with HarrisMartin Publishing on this topic.
HarrisMartin: At what point in a patient's history would a liver specialist such as yourself be called in to consult?
Tetri: I could be brought into the process at the first sign of minor abnormalities of the …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick